Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Study reveals underrepresentation of women in stroke clinical trials

A new study shows that women are underrepresented in stroke clinical trials relative to the number who have strokes in the general population.

13 Oct 2021

NYU Langone launches new center to advance scientific discovery and treatment of neurodegenerative diseases

NYU Langone Health announced today the launch of the Parekh Center for Interdisciplinary Neurology, made possible by a gift provided by Deven and Monika Parekh through the Psquared Charitable Foundation.

11 Oct 2021

The neurological effects of COVID-19

What is the relationship between COVID-19 and the brain? A new review published in Tropical Biomedicine summarizes the key findings on how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes severe COVID-19 infection, disrupts brain activity and produces a range of long-term neurological disorders.

10 Oct 2021

Tiny bubbles show promise for reducing inflammation

Scientists hope that tiny sacs of material excreted by cells - so-called extracellular vesicles - can be used to deliver drugs inside the body. Researchers at Karolinska Institutet now show that these nano-bubbles can transport protein drugs that reduce inflammation caused by different diseases.

6 Oct 2021

Toxic fatty acids trigger cell death in damaged neurons

Cells that normally nourish healthy brain cells called neurons release toxic fatty acids after neurons are damaged, a new study in rodents shows.

6 Oct 2021

Thrombolytic therapy may be safe for people with ischemic stroke and unruptured aneurysms

Clot-busting drugs are the main treatment for stroke, but they have often not been recommended for people who have an aneurysm in their brains that has not ruptured. An aneurysm is a bulge in the wall of a blood vessel in the brain.

6 Oct 2021

'Think twice' campaign effective in reducing opioid prescribing in primary care

A campaign that urged GPs to 'think-twice' before putting a patient on opioid medicines is effective in reducing opioid prescribing in primary care, according to the findings of a major study.

5 Oct 2021

Blacks, Latinos with autoimmune diseases experience poorer outcomes due to modifiable social conditions

Minority populations in the US with multiple sclerosis and other autoimmune diseases experience poorer outcomes due to modifiable social conditions, according to a new USC study.

5 Oct 2021

Scientists use new technique to study the effects of reactive electrophilic drugs

In 2014, the European Medicines Agency approved the drug Tecfidera for the treatment of relapsing multiple sclerosis, a neurodegenerative disease that affects millions of people worldwide. In multiple sclerosis, inflammation damages the protective myelin insulation around nerves, and the nerves themselves.

30 Sep 2021

New discovery may offer a promising avenue for study of multiple sclerosis

A surprising discovery may offer a promising new direction in the study of multiple sclerosis and other diseases of hypomyelination – when axons of neurons are not covered sufficiently in fatty sheaths (myelin), which disrupts communication between nerve cells.

23 Sep 2021

The impact of multiple sclerosis therapy on COVID-19 vaccine efficacy

In a paper, the vaccine-induced cellular and immune response of MS patients receiving a range of therapies are assessed.

23 Sep 2021

Study provides clearer understanding of how migraines affect sleep patterns

Adults and children with migraines may get less quality, REM sleep time than people who don't have migraines.

23 Sep 2021

People with neurologic conditions more likely to have had adverse childhood experiences

Adults with neurologic conditions are more likely than the general population to have had adverse childhood experiences such as abuse, neglect or household dysfunction, according to a study published in the September 22, 2021, online issue of Neurology Clinical Practice, an official journal of the American Academy of Neurology.

22 Sep 2021

COVID-19 induces the generation of distinct autoantibodies

In a recent study, the association between COVID-19 and autoimmunity is investigated at all levels of disease severity.

21 Sep 2021

Light exposure during pregnancy may be linked to fetal brain development

There may be a link between exposure to light during pregnancy and fetal brain development. New findings by researchers at Umeå University, Sweden, working in collaboration with American colleagues, may provide better understanding of certain neurological diseases later in life.

20 Sep 2021

Multiple sclerosis patients elicit robust T-cell responses to mRNA COVID-19 vaccines

New research shows that Multiple Sclerosis (MS) patients undergoing anti-CD20 (aCD20) treatment – which depletes the B cells that contribute to the MS attacks – are able to mount robust T-cell responses to the mRNA COVID-19 vaccines, despite having a muted antibody response to the vaccines.

17 Sep 2021

MS patients diagnosed with colorectal cancer may have shorter survival times, study finds

People with multiple sclerosis (MS) who are diagnosed with colorectal cancer may be at a higher risk of dying from cancer or other causes over the next six months to one year than people with colorectal cancer who do not have MS, according to a study published in the September 15, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.

16 Sep 2021

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Study reveals underrepresentation of women in stroke clinical trials

NYU Langone launches new center to advance scientific discovery and treatment of neurodegenerative diseases

The neurological effects of COVID-19

Tiny bubbles show promise for reducing inflammation

Toxic fatty acids trigger cell death in damaged neurons

Thrombolytic therapy may be safe for people with ischemic stroke and unruptured aneurysms

'Think twice' campaign effective in reducing opioid prescribing in primary care

Blacks, Latinos with autoimmune diseases experience poorer outcomes due to modifiable social conditions

Scientists use new technique to study the effects of reactive electrophilic drugs

New discovery may offer a promising avenue for study of multiple sclerosis

The impact of multiple sclerosis therapy on COVID-19 vaccine efficacy

Study provides clearer understanding of how migraines affect sleep patterns

People with neurologic conditions more likely to have had adverse childhood experiences

COVID-19 induces the generation of distinct autoantibodies

Light exposure during pregnancy may be linked to fetal brain development

Multiple sclerosis patients elicit robust T-cell responses to mRNA COVID-19 vaccines

MS patients diagnosed with colorectal cancer may have shorter survival times, study finds

Temedica and Roche collaborate to provide digital support for multiple sclerosis patients

MS patients receiving aCD20 treatment mount robust T-cell responses to COVID-19 vaccines

Rutgers study examines link between COVID-19 and memory loss, dementia

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Newsletters you may be interested in